RaphaelZ.BorokMDMEng

PubMed

• 369 citations
  Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes
  Azra Raza, Sefer Gezer, Suneel D. Mundle, XZ Gao, Sairah Alvi
  Blood. 1995-07-01
• 180 citations
  Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment
  James J. Rydel, Stephen M. Korbet, R. Z. Borok, Melvin M. Schwartz
  American Journal of Kidney Diseases. 1995-04-01
• 92 citations
  Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group.
  Richard P. Sloan, Melvin M. Schwartz, Stephen M. Korbet, R. Z. Borok
  Journal of the American Society of Nephrology. 1996-02-01

Abstracts/Posters

• A paradigm shift in myelodysplastic syndromes leads to novel anticytokine therapy.
  Raza A, Gezer S, Venugopal P, Shetty V, Mundle S, Chopra H, Span B, Dar S, Alvi S, Borok R, Gregory S, Priesler H, Cancer in the Elderly 1996 Conference, Tampa, FL, 11/13/1996
• Effect of antiphosphatidic drugs on the expression of cytokines in Myelodysplastic Syndromes (MDS).
  Shetty V, Dar S, Hussaini S, Alvi S, Span L, Mundle S, Gezer S, Gregory S, Venugopal P, Hines C, Chopra H, Borok R, Robin E, Rifkin S, Alston D, Hernandez B, Hsu WT, P..., 25th Annual Meeting of the International Society for Experimental Hematology, 8/23/1996
• The stem cell disorder in myelodysplastic syndromes is further confounded by complex cytokine effects in a study of 109 patients.
  Raza A, Dar S, Gezer S, Gregory S, Venugopal P, Hines C, Mundle S, Shetty V, Span L, Chopra H, Alvi S, Borok R, Robin E, Rifkin S, Alston D, Hernandez B, Hsu WT, Preis..., 25th Annual Meeting of the International Society for Experimental Hematology, 8/23/1996
• Anticytokine therapy produces modest responses in patients with myelodysplastic syndromes.
  Raza A, Gezer S, Gregory SA, Showel J, Venugopal P, Hines C, Thomas R, Alvi S, Mundle S, Shetty V, Borok R, Robin EL, Rifkin SD, Alston D, Hernandez BM, Shah R, 38th Annual Meeting of the American Society of Hematology, Orlando, FL, 1/1/1996
• Alternative mechanisms of DNA damage in myelodysplastic syndromes.
  Alvi S, Borok R, Bi S, Mundle S, Shetty V, Showel M, Venugopal P, Gezer S, Gregory S, Rifkin S, Robin E, Alston D, Shah R, Raza A, Proc. of the Cell Proliferation Society, 1/1/1996
• A study of apoptosis, proliferation and cytokines in Non-Hodgkins Lymphoma (NHL).
  Gregory S, Shetty V, Mundle S, Showel J, Alvi S, Borok R, Riley MB, Venugopal P, Gezer S, Wade EL, Raza A, Proc. of the Cell Proliferation Society, 1/1/1996
• Reversal of high incidence of apoptosis may improve the cytopenias of myelodysplastic syndromes (MDS).
  Raza A, Rifkin S, Gezer S, Mundle S, Parcharidou A, Shetty V, Alvi S, Borok R, Loew J, Gregory S, Cambridge Health tech Institute's third annual conference on Commercial Implications of Apoptosis, Cambridge, MA, 5/1/1995
• Proliferative fraction inversely related to the total white cell count in myelodysplastic syndromes (MDS).
  Borok R, Alvi S, Marcus B, Shetty V, Mundle S, Loew J, Gregory S, Rifkin S, Raza A, Cell Kinetics Society for the Annual Meeting, 1/1/1995
• Apoptosis is not neccessarily characteristic of neolastic cells in the Myelodysplastic Syndromes.
  Borok RZ, Alvi S, Bi S, Shetty V, Mundle S, Showel M, Gregory SA, Robin E, Venugopal P, Gezer S, Rifkin S, Alston S, Hernandez B, Preisler HD, Raza A, 87th Annual Meeting of the American Association for Cancer Research, Washington, DC, 1/1/1995
• Novel treatment of myelodysplastic syndromes(MDS) by suppression of high apoptotic intramedullary cell death.
  Raza A, Rifkin S, Showel J, Gregory S, Gezer A, Parcharidou A, Mundle S, Shetty V, Alvi S, Borok R, Loew J, Preisler H, Proc Am Soc of Clin Oncol, 1/1/1995
• Excessive intramedullary apoptotic cell death in myelodysplastic syndromes(MDS).
  Raza A, Gezer S, Mundle S, Shetty V, Alvi S, Borok R, Rifkin S, Loew J, Showel M, Showel J, Gregory S, Chaney C, Preisler H, Proc of the Fifth Joint Meeting of the Cell Kinetics Society and The International Cell Cycle Society; Cell Prolif, 1/1/1995
• Proliferation and apoptosis rates in 108 patients with myelodysplasia(MDS) and acute myeloid leukemia(AML).
  Raza A, Parcharidou A, Saikia T, Kochupillai V, Mundle S, Shetty V, Alvi S, Borok R, Gezer S, Loew J, Showel J, Showel M, Rifkin S, Gregory S, Proc of the Fifth Joint Meeting of the Cell Kinetics Society and The International Cell Cycle Society; Cell Prolif, 1/1/1995
• Expression of fas receptor and apoptosis in myelodysplastic syndrome and high risk acute myeloid leukemia.
  Alvi S,Borok R, Shetty V, Mundle S,Khan A, Gregory SA, Raza A, Cell Kinetics Society for the Annual Meeting, 1/1/1995
• Detection of high molecular weight DNA as evidence of apoptosis in myelodysplasia.
  Alvi S, Borok R, Mundle S, Gao X-Z, Shetty V, Hines C, Robin E, Rifkin S, Klein M, Alston S, Hernandez B, Hsu W-T, Gezer S, Gregory S, Raza A, Blood, 1/1/1995
• Extensive intramedullary apoptosis may be the basis for ineffective hematopoiesis in myelodysplastic syndromes.
  Raza A, Gezer S, Gregory S, Venugopal P, Hines C, Mundle S, Alvi S, Borok R, Robin E, Rifkin S, Klein M, Alston D, Hernandez B, Hsu W-T, Proc of the American Society of Hematology 37th Annual Meeting; Blood, 1/1/1995
• Join now to see all